調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Needle-free Drug Delivery Devices Market by Product and Geography - Forecast and Analysis 2020-2024

無針ドラッグデリバリーデバイスの世界市場：予測及び分析 2020-2024

◆タイトル：Needle-free Drug Delivery Devices Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード：IRTNTR40749
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2019年12月
◆ページ数：152
◆資料形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥265,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥318,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥424,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

本レポートは、無針ドラッグデリバリーデバイスの市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別（吸入器、経皮パッチ、ジェットインジェクター）分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。
・エグゼクティブサマリー
・レポートの範囲
・市場状況
・市場規模
・ファイブフォース分析
・無針ドラッグデリバリーデバイスの世界市場：製品別（吸入器、経皮パッチ、ジェットインジェクター）
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因と課題
・市場動向
・企業状況
・企業分析

Global Needle-Free Drug Delivery Devices Market: About this market
Technavio’s needle-free drug delivery devices market analysis considers sales from inhalers, transdermal patches, and jet injectors. Our study also finds the sales of needle-free drug delivery devices in Asia, Europe, North America, and ROW. In 2019, the inhalers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high incidence of asthma will play a significant role in the inhalers segment to maintain its market position. Also, our global needle-free drug delivery devices market report looks at factors such as the increasing prevalence of chronic disease, rising number of new product launches, and the growing number of strategic alliances. However, frequent product recalls, stringent regulations associated with drug-device combination products, and high costs associated with needle-free drug delivery devices may hamper the growth of the needle-free drug delivery devices industry over the forecast period.

Global Needle-Free Drug Delivery Devices Market: Overview
Increasing prevalence of chronic diseases
Chronic diseases such as diabetes, especially type 1 diabetes is on the rise. According to the OECD, in 2017, about 600 children per 100,000 children had type 1 diabetes in Finland. With growing pollution and respiratory infections, instances of asthma have also dramatically increased. Physicians use needle-free drug delivery devices to administer insulin to children with type 1 diabetes. These devices also prove to be quite effective in the immediate administration of asthmatic medications. Needle-free drug delivery devices administer drugs through the skin of patients either by using shock waves or as a pressure generated by gas or electrophoresis. With the increasing prevalence of various chronic diseases such as diabetes and asthma, the need for needle-free drug delivery devices is increasing, which will lead to the expansion of the global needle-free drug delivery devices market at a CAGR of over 4% during the forecast period.

Technological advances in needle-free drug delivery devices
The intense competition in the market is compelling vendors to invest in R&D to expand their product portfolios. They are developing innovative and advanced devices to administer regular medications for disease management. These devices facilitate the process of drug administration for the management of several diseases and health conditions. The integration of software with needle-free drug delivery devices helps patients to adhere to their regular regimen of medication and, at the same, allows physicians to analyze the condition of their patients and improve the management of chronic respiratory diseases, such as asthma. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global needle-free drug delivery devices market during the forecast period 2020-2024, click here.

Competitive Landscape
With the presence of several major players, the global needle-free drug delivery devices market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading needle-free drug delivery devices manufacturers, that include 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.
Also, the needle-free drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Inhalers – Market size and forecast 2019-2024
• Transdermal patches – Market size and forecast 2019-2024
• Jet injectors – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances in needle-free drug delivery devices
• Research and funding for development of needle-free drug delivery devices
• Increasing government initiatives
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• 3M Co.
• Antares Pharma Inc.
• Becton, Dickinson and Co.
• Enesi Pharma Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Mylan NV
• Novartis AG
• PharmaJet Inc.
• Valeritas Holdings Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO

 
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Inhalers – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Rate of hospital admissions for asthma and COPD (number of people per 100,000 population)
Exhibit 22: Inhalers – Year-over-year growth 2020-2024 (%)
Exhibit 23: Transdermal patches – Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Transdermal patches – Year-over-year growth 2020-2024 (%)
Exhibit 25: Jet injectors – Market size and forecast 2019-2024 ($ millions)
Exhibit 26: Jet injectors – Year-over-year growth 2020-2024 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2019-2024 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: North America – Year-over-year growth 2020-2024 (%)
Exhibit 33: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 35: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 37: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Estimated cases of children with type 1 diabetes 2017 (per 100,000 children)
Exhibit 42: Product launch
Exhibit 43: Strategic alliances
Exhibit 44: Product recalls
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: M Co. – Vendor overview
Exhibit 52: M Co. – Business segments
Exhibit 53: M Co. – Organizational developments
Exhibit 54: M Co. – Geographic focus
Exhibit 55: M Co. – Segment focus
Exhibit 56: M Co. – Key offerings
Exhibit 57: M Co. – Key customers
Exhibit 58: Antares Pharma Inc. – Vendor overview
Exhibit 59: Antares Pharma Inc. – Business segments
Exhibit 60: Antares Pharma Inc. – Organizational developments
Exhibit 61: Antares Pharma Inc. – Geographic focus
Exhibit 62: Antares Pharma Inc. – Key offerings
Exhibit 63: Antares Pharma Inc. – Key customers
Exhibit 64: Becton, Dickinson and Co. – Vendor overview
Exhibit 65: Becton, Dickinson and Co. – Business segments
Exhibit 66: Becton, Dickinson and Co. – Organizational developments
Exhibit 67: Becton, Dickinson and Co. – Geographic focus
Exhibit 68: Becton, Dickinson and Co. – Segment focus
Exhibit 69: Becton, Dickinson and Co. – Key offerings
Exhibit 70: Becton, Dickinson and Co. – Key customers
Exhibit 71: Enesi Pharma Ltd. – Vendor overview
Exhibit 72: Enesi Pharma Ltd. – Business segments
Exhibit 73: Enesi Pharma Ltd. – Organizational developments
Exhibit 74: Enesi Pharma Ltd. – Key offerings
Exhibit 75: Enesi Pharma Ltd. – Key customers
Exhibit 76: GlaxoSmithKline Plc – Vendor overview
Exhibit 77: GlaxoSmithKline Plc – Business segments
Exhibit 78: GlaxoSmithKline Plc – Organizational developments
Exhibit 79: GlaxoSmithKline Plc – Geographic focus
Exhibit 80: GlaxoSmithKline Plc – Segment focus
Exhibit 81: GlaxoSmithKline Plc – Key offerings
Exhibit 82: GlaxoSmithKline Plc – Key customers
Exhibit 83: Inovio Pharmaceuticals Inc. – Vendor overview
Exhibit 84: Inovio Pharmaceuticals Inc. – Business segments
Exhibit 85: Inovio Pharmaceuticals Inc. – Organizational developments
Exhibit 86: Inovio Pharmaceuticals Inc. – Key offerings
Exhibit 87: Inovio Pharmaceuticals Inc. – Key customers
Exhibit 88: Mylan NV – Vendor overview
Exhibit 89: Mylan NV – Product segments
Exhibit 90: Mylan NV – Organizational developments
Exhibit 91: Mylan NV – Geographic focus
Exhibit 92: Mylan NV – Segment focus
Exhibit 93: Mylan NV – Key offerings
Exhibit 94: Mylan NV – Key customers
Exhibit 95: Novartis AG – Vendor overview
Exhibit 96: Novartis AG – Business segments
Exhibit 97: Novartis AG – Organizational developments
Exhibit 98: Novartis AG – Geographic focus
Exhibit 99: Novartis AG – Segment focus
Exhibit 100: Novartis AG – Key offerings
Exhibit 101: Novartis AG – Key customers
Exhibit 102: PharmaJet Inc. – Vendor overview
Exhibit 103: PharmaJet Inc. – Business segments
Exhibit 104: PharmaJet Inc. – Organizational developments
Exhibit 105: PharmaJet Inc. – Key offerings
Exhibit 106: PharmaJet Inc. – Key customers
Exhibit 107: Valeritas Holdings Inc. – Vendor overview
Exhibit 108: Valeritas Holdings Inc. – Business segments
Exhibit 109: Valeritas Holdings Inc. – Organizational developments
Exhibit 110: Valeritas Holdings Inc. – Key offerings
Exhibit 111: Valeritas Holdings Inc. – Key customers
Exhibit 112: Validation techniques employed for market sizing
Exhibit 113: Definition of market positioning of vendors



【掲載企業】

3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。
[無針ドラッグデリバリーデバイスの世界市場：予測及び分析 2020-2024]についてメールでお問い合わせはこちら
◆関連調査資料◆
  • 湿疹治療薬の世界市場：予測及び分析 2020-2024
    IRTNTR40707 / Technavio / 2019年12月 / 本レポートは、湿疹治療薬の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、顧客状況、地域別状況、疾患別（アトピー性皮膚炎、接触皮膚炎、その他）分析、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・顧客状況 ・地域別状況 ・湿疹治療薬の世界市場：疾患別（アトピー性皮膚炎、接触皮膚炎、その他） ・意思決定フレームワーク...Global Eczema Therapeutics Market: About this market Technavio’s eczema therapeutics market analysis considers sales from atopic dermatitis, contact dermatitis, and other indication. Our study also finds the sales of eczema therapeutics in Asia, Europe, North America, and ROW. In 2019, the atopic dermatitis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high prevalence of chronic, highly pruritic inflammatory skin disorders will play a significant role in the atopic dermatitis segment to maintain its market position. Also, our global eczema therapeutics market report looks at factors such as...
  • コンジュゲートワクチンの世界市場：予測及び分析 2020-2024
    IRTNTR40714 / Technavio / 2019年12月 / 本レポートは、コンジュゲートワクチンの市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、種類別（多価コンジュゲートワクチン、一価コンジュゲートワクチン）分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・コンジュゲートワクチンの世界市場：種類別（多価コンジュゲートワクチン、一価コンジュゲートワクチン） ・顧客状況 ・地域別状況 ・意思決定フレームワーク...Global Conjugate Vaccines Market: About this market Technavio’s conjugate vaccines market analysis considers sales from the multivalent conjugate vaccine and monovalent conjugate vaccine types. Our study also finds the sales of conjugate vaccines in Asia, Europe, North America, and ROW. In 2019, the multivalent conjugate vaccine segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive diseases will play a significant role in the multivalent conjugate vaccine segment to maintain its market position. Also, our global conjugate vaccines market...
  • 心臓移植治療薬の世界市場：予測及び分析 2020-2024
    IRTNTR40272 / Technavio / 2019年12月 / 本レポートは、心臓移植治療薬の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別（免疫抑制剤、補助薬）分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・心臓移植治療薬の世界市場：製品別（免疫抑制剤、補助薬） ・顧客状況 ・地域別状況 ・意思決定フレームワーク...Global Heart Transplantation Therapeutics Market: About this market Technavio’s heart transplantation therapeutics market analysis considers sales from immunosuppressants and supplementary medications products. Our study also finds the sales of heart transplantation therapeutics in Asia, Europe, North America, and ROW. In 2019, the immunosuppressants segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as mechanism of actions (MoA) of these drugs to treat and prevent organ rejection will play a significant role in the immunosuppressants segment to maintain its market position. Also, our global heart transplantation therapeutics market report looks at...
  • ワクチンの世界市場予測・分析2020-2024
    IRTNTR40041 / Technavio / 2019年11月10日 / Technavio社の本調査レポートでは、ワクチンの世界市場について調べ、ワクチンの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、ワクチンの市場規模をセグメンテーション別（種類別（予防ワクチン、治療ワクチン）、）と地域別（グローバル）に分けて算出しました。Technavio社はワクチンの世界市場規模が2020-2024期間中に年平均7%成長すると予測しています。 ・サマリー ・レポートの範囲 ・ワクチンの市場状況 ・ワクチンの市場規模 ・ワクチンの市場予測 ・ワクチンの世界環境：ファイブフォース分析 ・市場セグメンテーション：種類別（予防ワクチン、治療ワクチン） ・ワクチンの顧客状況 ・主要地域別市場規模：グローバル...Global Vaccines Market: About this market Technavio’s vaccines market analysis considers sales from both prophylactic vaccines and therapeutic vaccine types. Our analysis also considers the sales of vaccines in Asia, Europe, North America, and ROW. In 2019, the prophylactic vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as high safety and efficacy will play a significant role in the prophylactic vaccines segment to maintain its market position. Also, our global vaccines market report looks at factors such as increased funding for vaccine development and new vaccine launches, approval...
  • 有効成分の世界市場：予測及び分析 2020-2024
    IRTNTR40608 / Technavio / 2019年12月 / 本レポートは、有効成分の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、顧客状況、製造タイプ別（キャプティブAPI、コントラクトAPI）分析、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・顧客状況 ・有効成分の世界市場：製造タイプ別（キャプティブAPI、コントラクトAPI） ・地域別状況 ・意思決定フレームワーク...Global Active Pharmaceutical Ingredients Market: About this market Technavio’s active pharmaceutical ingredients market analysis considers sales from captive API and contract API. Our study also finds the sales of active pharmaceutical ingredients in Asia, Europe, North America, and ROW. In 2019, the contract API segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing demand for low-cost drugs will play a significant role in the contract API segment to maintain its market position. Also, our global active pharmaceutical ingredients market report looks at factors such as evolving API...
  • 神経診断および監視デバイスの米国市場：予測及び分析 2020-2024
    IRTNTR40602 / Technavio / 2019年12月 / 本レポートは、神経診断および監視デバイスの市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別（ICP監視デバイス、EEGデバイス、EMGデバイス、その他）分析、顧客状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・神経診断および監視デバイスの世界市場：製品別（ICP監視デバイス、EEGデバイス、EMGデバイス、その他） ・顧客状況 ・意思決定フレームワーク ・市場の要因と課題...Neurodiagnostic and Monitoring Devices Market in the US: About this market Technavio’s neurodiagnostic and monitoring devices market in the US analysis considers sales ICP monitoring devices, EEG devices, EMG devices, and other products. In 2019, the ICP monitoring devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing number of traumatic brain injury and brain tumor cases will play a significant role in the ICP monitoring devices segment to maintain its market position. Also, our neurodiagnostic and monitoring devices market in the US report looks at factors...
  • EEGおよびEMGの世界市場：予測及び分析 2020-2024
    IRTNTR40609 / Technavio / 2019年12月 / 本レポートは、EEGおよびEMGの市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別（EEGデバイス、EMGデバイス）分析、顧客状況、地域別状況、エンドユーザー別（病院およびクリニック、ASC、その他）分析、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・EEGおよびEMGの世界市場：製品別（EEGデバイス、EMGデバイス） ・顧客状況 ・地域別状況 ・EEGおよびEMGの世界市場：エンドユーザー別（病院およびクリニック、ASC、その他）...Global EEG and EMG Devices Market: About this market Technavio’s EEG and EMG devices market analysis considers sales from both EEG devices and EMG devices. Our study also finds the sales of EEG and EMG devices in Asia, Europe, North America, and ROW. In 2019, the EEG devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of neurological diseases will play a significant role in the EEG devices segment to maintain its market position. Also, our global EEG and EMG devices market report looks at...
  • 体外膜酸素化装置の世界市場：予測及び分析 2020-2024
    IRTNTR40185 / Technavio / 2019年11月 / 本レポートは、体外膜酸素化装置の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、顧客状況、地域別状況、治療法別（静脈および動静脈、静脈動脈）分析、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・顧客状況 ・地域別状況 ・体外膜酸素化装置の世界市場：治療法別（静脈および動静脈、静脈動脈） ・意思決定フレームワーク...Global Extracorporeal Membrane Oxygenation Machines Market: About this market Technavio’s extracorporeal membrane oxygenation machines market analysis considers sales from veno-venous and arterio-venous; and veno-arterial modalities. Our study also finds the sales of extracorporeal membrane oxygenation machines in Asia, Europe, North America, and ROW. In 2019, the veno-venous and arterio-venous segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing cases of lung transplants will play a significant role in the veno-venous and arterio-venous segment to maintain its market position. Also, our global extracorporeal membrane oxygenation machines market report looks...
  • 歯内用品の世界市場：予測及び分析 2020-2024
    IRTNTR40203 / Technavio / 2019年11月 / 本レポートは、歯内用品の市場実態を調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、顧客状況、製品別（歯内バーと栓塞子、歯内スケーラー、歯内治療用ファイル）分析、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析を掲載しています。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・顧客状況 ・歯内用品の世界市場：製品別（歯内バーと栓塞子、歯内スケーラー、歯内治療用ファイル） ・地域別状況 ・意思決定フレームワーク...Global Endodontic Supplies Market: About this market Technavio’s endodontic supplies market analysis considers sales from endodontic burs and obturators, endodontic scalers, and endodontic files. Our study also finds the sales of endodontic supplies in Asia, Europe, North America, and ROW. In 2019, the endodontic burs and obturators segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as technological advances and enhanced OLED interface will play a significant role in the endodontic burs and obturators segment to maintain its market position. Also, our global endodontic supplies market report looks at factors...
  • 世界の歯科生体材料市場予測・分析2020-2024
    IRTNTR40190 / Technavio / 2019年11月 / 本調査レポートは歯科生体材料の世界市場について調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別（骨移植、膜及び組織再生製品）分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析などを含め、次の構成でお届けいたします。 ・エグゼクティブサマリー ・レポートの範囲 ・市場状況 ・市場規模 ・ファイブフォース分析 ・歯科生体材料の世界市場：製品別（骨移植、膜及び組織再生製品） ・顧客状況 ・地域別状況 ・意思決定フレームワーク...Global Dental Biomaterials Market: About this market Technavio’s dental biomaterials market analysis considers sales from bone grafts and membranes and tissue regeneration products. Our study also finds the sales of dental biomaterials in Asia, Europe, North America, and ROW. In 2019, the bone grafts segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the launch of innovative grafts and technological advances will play a significant role in the bone grafts segment to maintain its market position. Also, our global dental biomaterials market report looks at factors such as the...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆